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Results: Acute DVT occurred in 7.3%, and chronic DVT occurred in
9.7% of patients studied (24.0% inpatients, 60.9% female; mean age, 56.3
years [range, 4-91 years, 1.1% aged 16 years]). History of previous DVT
(74.0%) and smoking (38.0%) were the most common risk factors in patients
with DVT. Iliac DVT was identified in 9.6% of acute DVT and in 5.7% of
chronic DVT. Common femoral DVT was identified in 30.8% of acute DVT
and in 22.9% of chronic DVT. CDL was used in 14.3% and thrombectomy
in 4.8% of acute iliac/common femoral DVT and was never used with distal
DVT.Warfarin anticoagulation with or without heparin/enoxaparin overlap
was the most common treatment for acute (58.5%) and chronic (48.6%)
iliac/common femoral DVT. In 2008 the referral base of the IU laboratory
increased significantly. Acute DVT occurred significantly less often during
the 1-year period of 2008 (5.3%) than in the 10-year period 1998 to 2007
(7.6%), but iliac/common femoral DVT as a component of acute DVT did
not differ significantly (40.0% in 2008, 41.9% in 1998-2007).
Conclusions: Iliac/common femoral DVT affects almost half of pa-
tients with acute DVT. Current recommendations of acute thrombus re-
moval for the treatment of iliofemoral DVT is under-utilized, suggesting
that perhaps greater education of clinicians and patients regarding invasive
therapy for iliofemoral DVT is necessary.
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Background: Chronic venous disorders (CVD) are among the most
common diseases in Germany. In the Bonn Vein Study I (BVS I), conducted
in 2000, 3072 participants (1350 men, 1722 women) of the general
population of the city of Bonn and two rural townships, aged 18 to 79 years,
took part. Participants were selected by simple random sampling from the
registries of residents. In this follow-up study 6.6 years later, the same
population was investigated again to identify the incidence of newly devel-
oped CVD and of progression of pre-existing CVD.
Methods: From May 2007 to September 2008, we contacted all BSV
I participants and invited them for a reinvestigation. The participants an-
swered a standardized questionnaire and were examined by clinical means
and by duplex ultrasound imaging in the same way as in BVS I.
Results: The response at follow-up after 6.6 years was 84.6%. We
reinvestigated 1978 participants. The prevalence for varicose veins rose from
22.7% to 25.1% and for chronic venous insufficiency (CVI) from 14.5% to
16%. The incidence for new varicose veins was 13.7% and for newCVI 13.0%
per 6.6 years, increasing with age. Participants with CEAP class C2 as a
maximum at BVS I increased to higher C classes in 19.8% (nonsaphenous
varicose veins) and in 31.8% (saphenous varicose veins).
Conclusions: These results show a high incidence of about 2% for
varicose veins and for CVI per year. During the same time, the incidence of
progression to higher C classes seems to be very high.
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Background: Decreased venous tone and vein wall dilation secondary
to venous hypertension may contribute to varicose vein formation. We have
shown that prolonged increases in vein wall tension are associated with
overexpression of matrix metalloproteinases (MMPs) and increased venous
relaxation. Expression of hypoxia-inducible factors (HIFs) also increases
with mechanical stretch. This study assessed whether upregulation of HIF is
an intermediary mechanism linking the prolonged increases in vein wall
tension to the changes in venous contraction and MMP expression.
Methods: Circular segments of inferior vena cava (IVC) from male
Sprague-Dawley rats were suspended between two wires in a tissue bath.
IVC segments were subjected to control 0.5g basal tension for 1 hour. After
eliciting a control contraction to KCl (96mM) and phenylephrine (PHE,
10-5M), the veins were exposed to prolonged 18 hours of basal tension at
0.5g, 2g, 2g plus HIF inhibitor (U-0126 10-5M, 17-DMAG 10-5M, echi-
nomycin 10-6M), or 2g plus dimethyloxallyl glycine (10-4M), a prolyl-
hydroxylase inhibitor that stabilizes HIF. The fold-change in contraction to
KCl or PHE after prolonged tension for 18 hours was compared with the
corresponding initial contraction at 0.5g tension for 1 hour. Vein homoge-
nates were analyzed for HIF-1, HIF-2, MMP-2, and MMP-9 expression
using real-time reverse transcription polymerase chain reaction.
Results: Compared with control IVC contraction at 0.5g tension for 1
hour, the contraction to KCl and PHE at prolonged 0.5g tension for 18
hours was 1.1 0.06 and 2.0 0.35, respectively. KCl- and PHE-induced
contraction at prolonged 2g tension was significantly reduced (0.72 0.05
and 0.87  0.13, respectively). KCl-induced contraction was restored in
IVC exposed to prolonged 2g tension plus the HIF inhibitor U0126
(1.14 0.05) or echinomycin (1.11 0.15). U0126 and echinomycin also
restored PHE-induced IVC contraction after prolonged 2g tension (1.38
0.15 and 1.99  0.40, respectively). Stabilization of HIF using DMOG
further reduced KCl and PHE-induced contraction in veins under pro-
longed 2g tension (0.57 0.01 and 0.47 0.06, respectively), implicating
HIF in the reduced contraction associated with prolonged stretch. HIF-1
and HIF-2 messenger RNA expression was increased in IVC segments
under prolonged 2g tension, and reversed in IVC treated with U0126,
17-DMAG, or echinomycin. The overexpression of HIF was associated with
increased MMP-2 and MMP-9 mRNA expression.
Conclusions: Prolonged increases in vein wall tension are associated
with overexpression of HIF-1 andHIF-2 in rat IVC. The upregulation of
HIF is associated with increased MMP-2 and MMP-9 expression and
reduced venous contraction. The data suggest that the increased vein wall
tension secondary to venous hypertension may induce HIF overexpression
and cause an increase in MMPs expression and reduction of venous contrac-
tion, leading to progressive venous dilation and varicose vein formation.
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Background: Saponosides such as horse chestnut seed extract (escin)
exhibit venotonic properties that have been used in the treatment of varicose
veins. Escin is known to form pores in the cell membrane, but the cellular
mechanisms underlying its venotonic properties and long-term effects on
venous function are unclear. Because Ca2 is a major regulator of venous
smooth muscle function, we tested the hypothesis that escin promotes
Ca2-dependent mechanisms of venous contraction.
Methods: Circular segments of inferior vena cava (IVC) were isolated
frommale Sprague-Dawley rats and suspended between two wires in a tissue
bath filled with Krebs solution for measurement of isometric contraction.
After control contraction to 96mM KCl, the effect of increasing concentra-
tions of escin (10-10 to 10-4M) on venous contraction wasmeasured. To test
for Ca2-independent effects, the response to increasing concentrations of
escin was measured in Ca2-free (2mM ethyleneglycotetraacetic acid)
Krebs. To test for Ca2-dependent effects, IVC segments pretreated with
escin (10-4 M) were incubated in 0 Ca2 Krebs for 5 minutes, then
increasing extracellular CaCl2 concentrations (0.1, 0.3, 0.6, 1, 2.5mM)were
added and the [Ca2]e-contraction relationship was constructed. Contrac-
tion data were presented as mg/mg tissue (means  standard error of the
mean).
Results: In IVC, the -adrenergic agonist phenylephrine (PHE, 10-5
M) and membrane depolarization by 96mMKCl caused significant contrac-
tion (175.4  21.1 and 216.5  24.2, respectively). In normal Krebs
(2.5mM Ca2), escin caused concentration-dependent contraction, reach-
ing a maximum of 115.7  15.3 at 10-4 M. The escin-induced contraction
was reversible. After being washed three times with Krebs, the veins returned
to a relaxed state, suggesting that the escin-induced contraction is not a rigor
state. In Ca2-free Krebs, there was essentially no contraction in response to
increasing concentrations of escin (1.9  1.9 at 10-4M), supporting that
escin-induced contraction is not solely due to its pore-forming properties,
potential loss of intracellular adenosine triphosphate, and consequent con-
tractile rigor. In escin-treated veins incubated in 0 Ca2 Krebs, stepwise
addition of extracellular CaCl2 caused corresponding increases in contrac-
tion that reached a maximum of 76.9  15.3 at 2.5mM CaCl2. In IVC
segments pretreated with escin (10-4M) for 2 hours, PHE caused a small
contraction (5.8  3.6, P  .001), and KCl-induced contraction was
significantly reduced (82.3  14.8, P  .026).
Conclusions: In rat IVC, escin induces extracellular Ca2-dependent
contraction that could translate into measurable venotonic effects. How-
ever, escin also disrupts -adrenergic receptor-mediated pathways and de-
polarization-induced Ca2 entry-dependent vein contraction. Thus the
initial venotonic benefits of escin may be offset by long-term disruption of
venous smooth muscle response to vasoactive stimuli and thereby limit its
long-term therapeutic benefit in varicose veins.
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Background: The natural history of venous reflux in patients with
chronic venous disease (CVD) remains unclear. This study assessed the
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pattern of venous reflux on duplex ultrasound imaging in patients with
primary CVD.
Methods: A retrospective analysis was performed of duplex ultrasound
reports of patients with CVD in one institution between January 1, 2000,
and August 31, 2009. Excluded were patients with secondary CVD and
limbs previously treated with open surgery, endovenous ablation, and injec-
tion sclerotherapy, as were patients whose scan reports contained inadequate
information. Subgroup analysis was performed to compare the pattern of
venous reflux in men and women, and three age groups (30, 30-60, 60
years). The 2 test was used. P  .05 was considered significant.
Results: The Fig summarizes the limbs that were included and ex-
cluded. After exclusion, 2888 patients (1084 men and 1804 women; mean
age, 53.8 years; range, 11.9-101.2 years) were included for analysis. Saphe-
nofemoral junction (SFJ) reflux was demonstrated in 53% of limbs (2137 of
4020; men, 58%; women, 50%; P  .0001). No significant difference was
noticed in the proportion of SFJ incompetence between age groups (P 
.9866). Great saphenous vein (GSV) reflux was found in 82% of limbs (3303
of 4020; men, 84%; women, 81%; P .0044). No significant difference was
observed in the proportion of GSV incompetence between age groups (P
.2035). Saphenous-popliteal junction (SPJ) reflux was found in 22% of limbs
(871 of 4020; men, 21%; women, 22%; P  .2829). The percentage of SPJ
incompetence was not significantly different between age groups (P 
.0687). Small saphenous vein (SSV) incompetence was shown in 30% of
limbs (1224 of 4020; men, 33%; women, 29%; P  .0117). A significant
difference was also noted in the proportion of SSV reflux in between age
groups (P .0167). Of 1883 limbs with a competent SFJ, 1280 (68%) had
refluxing GSV, and 51% of limbs (762 of 1479) with competent GSV above
the knee showed GSV reflux below the knee. Five percent of limbs with an
incompetent SFJ and distal GSV had a competent proximal GSV (81 of
1621). Furthermore, 20% of limbs (630 of 3149) with competent SPJ
demonstrated refluxing SSV.
Conclusions: Reflux does not invariably originate at junctions of
patients with primary CVD. There appears to be multifocal initiation of
disease rather than following the ascending or descending theory. Some
variations were observed between men and women and in different age
groups. This pattern of venous reflux is likely to be due to primary venous
wall changes rather than primary valvular dysfunction.
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Background: Venous ulcerations are frequently slow to heal and
recurrent, causing major disability in afflicted persons. This retrospective
study examined outcomes of aggressive endovenous therapy in promoting
ulcer healing or preventing ulcer recurrence, or both.
Methods: In 2007 and 2008, 340 patients with venous insufficiency
were treated in an academic health science center vein clinic. Reviewed were
the medical records of 68 patients (18.8%) with severe chronic venous
disease: 43 (73%) at C5, and 25 (37) at C6. Data analysis included body mass
index (BMI), history of deep vein thrombosis (DVT), or prior vein surgery,
and type of procedure , including radiofrequency ablation of great saphe-
nous vein (GSV) alone or GSV and perforator ablation (GSVP). Complica-
tions, ulcer healing rates, and recurrent ulcerations were examined. Descrip-
tive statistics are reported and contingency tables are used when appropriate.
Results: The patients (24 men, 44 women) were aged 63  16 years,
with a BMI of 32.4 kg/m2 (range, 20.8-53.4 kg/m2). Duplex scanning
showed that all patients had GSV insufficiency, and 30 (44%) had deep vein
incompetence. Only 19 (28%) had a history of a DVT, and 13 (19%) had
prior vein procedures. Before undergoing ablation, 25 patients with C6
disease were conservatively treated with compression for an average of 5.4
months (range, 1-13 months). Ablation alone of the GSV was performed in
49 patients (72%) and perforator ablation of the GSV was conducted in 19
(28%). Only two patients (2.9%) experienced complications. One patient
had excessive hemosiderin staining; another patient had paresthesias. Of the
C5 patients treated, recurrent ulcerations developed in two (4.7%). An
appreciably greater percentage of C6 patients, 20% (n  5), did not heal
completely or developed a recurrent ulcer. The Table shows the comparison
of C5 and C6 patients treated with and without the addition of perforator
interruption. Prior treatment with compression, a history of DVT, and/or
prior venous procedures did not affect patient outcomes.
Conclusions:Chronic venous insufficiency with active or healed ulcer-
ation is commonly seen in our academic health science center vein clinic. In
this series, endovenous ablation allowed for excellent healing rates and
acceptable recurrent ulcer rates. It is unclear from this small cohort whether
the addition of perforator ablation was of benefit in improving venous
hemodynamics.
Table. Comparison of C5 and C6 patients
Variable C5 C6 P
Patients, No. 43 25
Age, y 61.8 66.5 NS
Body mass index, kg/
m2
34.1 30.6 NS
Gender (male/female) 11/32 13/12 .028
Deep vein insufficiency 18 13 NS
GSV/GSVP 31/12 16/9 NS
Recurrent or
nonhealing ulcer
2 5 .049
GSV, Great saphenous vein; GSVP, GSV perforator ablation;NS, not signif-
icant.
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Background: With the expansion of the American Venous Forum
(AVF), National Venous Screening Program (NVSP) in 2007, several stan-
dard venous assessment tools were incorporated into the screening process
as independent determinants of venous disease severity, but correlation
between these instruments has not been tested. The scope of this study was
to assess the validity of the Venous Clinical Severity Score (VCSS) and its
integration with other venous assessment tools as a global venous screening
instrument.
Methods: NVSP data registry for the past 2 years was queried for
participants with complete data sets including CEAP clinical staging, VCSS,
modified Chronic Venous Insufficiency Quality of Life Questionnaire
(CIVIQ) quality of life (QOL) assessment, and venous ultrasound results.
Statistical correlation trends were analyzed using Spearman rank coefficient
as related to VCSS.
Results: A total of 5814 limbs in 2907 participants were screened and
included CEAP clinical stage C0, 26%; C1, 33%; C2, 24%; C3, 9%; C4, 7%;
C5, 0.5%; and C6, 0.2% (mean, 1.411.22). Mean VCSS mean distribution
(range, 0-3) for the entire cohort included pain, 1.01 0.80; varicose veins,
0.61  0.84; edema, 0.61  0.81; pigmentation, 0.15  0.47; inflamma-
tion, 0.07  0.33; induration, 0.04  0.27; ulcer number, 0.004  0.081;
ulcer size, 0.007 0.112; ulcer duration, 0.007 0.134; and compression,
Fig. Flow chart shows inclusion and exclusion of limbs for analy-
sis. DVT, Deep vein thrombosis.
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